InvestorsHub Logo
Followers 166
Posts 10466
Boards Moderated 0
Alias Born 07/27/2012

Re: None

Wednesday, 12/04/2013 6:47:10 PM

Wednesday, December 04, 2013 6:47:10 PM

Post# of 38634
Great Conference!

Mr Rampertab stated,

Quote,

" Business Development discussions are quite active right now "

Also,

IPCI is generating it's first Revenues off product
Commercialization.
IPCI will have an additional ANDA filed by the end of this
year, early next year.
IPCI is near obtaining new Licensing Agreements and
New Distribution Opportunities.
IPCI is due to release additional Rexista Phase I studies
by the end of the year.
IPCI has three FDA ANDA candiates for approval for next year,
it's generics for Glucophage, Elexxor, and Protonix products.

IPCI has an amazing opportunity for it's Seroquel Generic
for 2016.
IPCI was the first to settle with Astra Zenica, and is now
positioned as the first to file it's generic for Seroquel,
which has a Market of over 1 Billion dollars.

Longer term, IPCI intends to be in a position to both
Manufacture and Launch it's own FDA approved product pipeline.

IPCI has a strong Pipeline including 7 ANDA's up for
FDA approval.

I don't know what one could ask for in an young Pharma
Company Investment.

Strong Buy at these levels.

Exciting Times!!!